Dusa, River's Edge Settle Acne Drug Patent Dispute

Law360, New York (October 29, 2007, 12:00 AM EDT) -- River's Edge LLC has agreed to permanently cease making and selling a generic version of Dusa Pharmaceuticals Inc.'s acne treatment Nicomide as part of a settlement that will put to rest a patent infringement lawsuit brought against River's Edge in April 2006.

In addition to stopping the manufacture and sale of its nicotinamide product NIC 750, River's Edge will make a lump-sum payment to Dusa, and concede that Dusa's patent is valid and enforceable, Dusa said Monday.

River's Edge will also stop participating in the re-examination...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.